SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-006243
Filing Date
2020-04-13
Accepted
2020-04-13 17:22:12
Documents
3
Period of Report
2020-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 34746
2 ex10-1.htm EX-10.1 140908
3 ex99-1.htm EX-99.1 49775
  Complete submission text file 0001493152-20-006243.txt   226927
Mailing Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9
Business Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9 (416) 214-3678
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

IRS No.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-56074 | Film No.: 20789427
SIC: 3841 Surgical & Medical Instruments & Apparatus